About this trial
This study compares two commonly used intracanal medicaments-Triple Antibiotic Paste and Calcium Hydroxide-in patients with infected single-rooted teeth. The purpose is to determine which medicament promotes faster healing of periapical lesions after root canal treatment by measuring reduction in lesion size and improvement in bone density over 3, 6, and 12 months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Systemically healthy adult patients between 18 and 65 years of age.
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Triple Antibiotic Paste
DrugIntracanal medicament paste composed of Ciprofloxacin, Metronidazole, and Minocycline. Placed in the root canal for several weeks.
Calcium Hydroxide (Ca(OH)2)
DrugStandard intracanal medicament with high pH, used for its antibacterial and tissue-stimulating properties. Placed in the root canal for several weeks
Treatment groups
Trial outcomes
Primary outcomes
Change in Periapical Lesion Area
Percentage reduction in the area (mm²) of the periapical radiolucency from baseline, as measured on standardized periapical radiographs or CBCT scans.
Secondary outcomes
Change in Periapical Bone Density Score
Improvement in a standardized bone density score or grayscale value of the periapical bone from baseline
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Faiz ur rahman
Lead sponsor
College of Physicians and Surgeons Pakistan
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: